Contact A Lawyer
Have A Potential Case Reviewed By An Attorney
A hundreds of people nationwide have reported experiencing problems with the Stryker Rejuvenate and ABG II hip implants, which were recalled in July 2012 amid reports of failures caused by corrosion, fretting and loosening of the modular neck stem. In many cases, these problems have led to the need for a hip revision surgery and resulted in permanent injuries.
STRYKER REJUVENATE HIP REPLACEMENT LAWSUIT STATUS: In 2014, a global Stryker Rejuvenate settlement was reached by the manufacturer to resolve all cases where plaintiffs underwent revision surgery on or before November 2, 2014. However, additional Stryker Rejuvenate hip lawsuits are being reviewed for individuals who have experienced problems that may have been caused by design defects with the artificial hip.
MANUFACTURER: Howmedica Osteonics, doing business as Stryker Medical.
OVERVIEW: The Stryker Rejuvenate and ABG II are modular neck stems that feature two pieces that fit inside the other to allow the surgeon to customize the length of the femoral component based on the patient. This differs from most traditional hip implants, which feature a single femoral component.
As the metal components rub against each other during normal everyday activity, microscopic metal debris may be released into the body. This may result in metal blood poisoning, or metallosis, which increases the risk of the components loosening and failing.
STRYKER REJUVENATE AND ABG II HIP RECALL: In July 2012, a Stryker Rejuvenate recall was issued for the Rejuvenate and ABG II modular hip components. The manufacturer acknowledged that the artificial hips were prone to corrode or fret at the modular junction, increasing the risk of inflammation, loosening and failure within a few years.
Although hip replacements are typically designed to last 15 to 20 years, the Stryker recalled the Rejuvenate and ABG II hip components were recalled after less than four years on the market.
Prior to removing the Stryker Rejuvenate and ABG II hips from the market, more than 20,000 of the components were sold nationwide. As these components remain in place, an increasing number of individuals are expected to experience a failure of their Stryker Rejuvenate hip, which could be caused by:
- Tissue Death
- Bone Necrosis
- Hip Replacement Loosening
LATEST DEVELOPMENTS IN STRYKER HIP REPLACEMENT LITIGATION: A growing number of lawsuits have been filed in state and federal courts throughout the country involving similar allegations that Stryker designed and sold a defective and unreasonably dangerous system.
The complaints allege that hip maker failed to warn patients and the medical community about the potential risk of Stryker Rejuvenate complications that could develop within a few years after surgery.
In June 2013, a panel of federal judges consolidated the Stryker Rejuvenate litigation, including all complaints filed in U.S. District Courts throughout the country involving a Rejuvenate or ABG II hip component. An MDL, or multidistrict litigation, was established in the U.S. District Court for the District of Minnesota before U.S. District Judge Donovan W. Frank, who will handled all pretrial proceedings for the lawsuits in order to avoid duplicative rulings and discovery, and to serve the convenience of both parties, witnesses and the courts.
The court will likely select some cases for early trials, known as bellwether trials. These test cases will allow all parties to see how juries are likely to respond to arguments, witness testimony and evidence that will be common throughout the litigation and could form the basis of a Stryker Rejuvenate and ABG II hip settlement.